Страна: Австралия
Язык: английский
Источник: Department of Health (Therapeutic Goods Administration)
Factor VIII, Quantity: 500 IU; Von willebrand factor, Quantity: 1200 IU
CSL Behring Australia Pty Ltd
Factor VIII,Von willebrand factor
Injection, diluent for
Excipient Ingredients:
Intravenous
Glass vial containing 500 IU FVIII, 1200 IU vWF supplied with 1 x 5mL diluent vial
exempt from scheduling - Appendix A; prescription medicine
The prophylaxis and treatment of non-surgical and surgical bleeding in patients with von Willebrand disease when desmopressin (DDAVP) treatment is ineffective or contraindicated. The prophylaxis and treatment of non-surgical and surgical bleeding associated with factor VIII deficiency due to haemophilia A.
Visual Identification: Clear and colourless; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius
Licence status A
2010-05-21